IPT-803
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
IPT-803 is a drug described as a dopamine modulator and opioid receptor antagonist which is or was under development for the treatment of Parkinson's disease. It is under development by Tools4Patient. The drug's exact mechanism of action is unclear, but may involve dopamine and endorphin pathways. As of June 2020, it is in phase 1/2 clinical trials. There have been no more recent developments since then. The chemical structure of IPT-803 does not yet appear to have been disclosed.
IPT-803 is a drug described as a dopamine modulator and opioid receptor antagonist which is or was under development for the treatment of Parkinson's disease. It is under development by Tools4Patient. The drug's exact mechanism of action is unclear, but may involve dopamine and endorphin pathways. As of June 2020, it is in phase 1/2 clinical trials. There have been no more recent developments since then. The chemical structure of IPT-803 does not yet appear to have been disclosed.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1336168577 under CC BY-SA 4.0; modifications have been made.